Journal of the American Society of Hypertension
Volume 2, Issue 3 , Pages 140-151, May 2008

Beyond blood pressure: Arterial stiffness as a new biomarker of cardiovascular disease

  • Stanley S. Franklin, MD, FACP, FACC, FAHA, FASN

      Affiliations

    • Corresponding Author InformationCorresponding author: Stanley S. Franklin, MD, FACP, FACC, FAHA, FASN, Heart Disease Prevention Program, C-240 Medical Sciences, University of California, Irvine, California. Tel: 310-472-8743; fax: 310-472-9974.

Heart Disease Prevention Program, University of California, Irvine, California, USA

Received 16 August 2007; accepted 7 September 2007.

Abstract 

Arterial stiffness of the large, elastic conduit arteries is considered a risk marker of vascular aging, as well as a new biomarker of cardiovascular (CV) disease. Arterial stiffness also plays an important role in the development of isolated systolic hypertension (ISH) in the middle-aged and elderly population. ISH is characterized by an increase in pulse pressure (PP) in association with a rise in systolic blood pressure (SBP) and a fall in diastolic blood pressure (DBP). Increased PP, however, is not always a good surrogate for arterial stiffening because of the frequent discrepancy between peripheral brachial and central aortic PP values due to varying pressure amplification. Therefore, noninvasive, easily performed methods for more direct measurement of arterial stiffness and wave reflection, such as aortic pulse wave velocity (PWV) and pulse wave analysis, have been developed for clinical use. The present review aims to provide an understanding of the pathophysiology of arterial stiffness and wave reflection, to review the various techniques for their measurement, and to explore their usefulness in predicting CV risk and therapeutic benefit in comparison with traditional brachial artery cuff blood pressure (BP) by sphygmomanometry.

Keywords: Hypertension, pulse pressure, pulse wave velocity, pulse wave analysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Franklin is on the Speakers Bureau for Boehringer Ingelheim, Bristol-Myers Squibb, and Merck, and a Consultant for AtCor Medical, and Bristol-Myers Squibb.

PII: S1933-1711(07)00194-5

doi:10.1016/j.jash.2007.09.002

Journal of the American Society of Hypertension
Volume 2, Issue 3 , Pages 140-151, May 2008